Department of Biology, Stanford University, Stanford, CA 94305, USA.
Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
Sci Adv. 2024 Oct 25;10(43):eadq6858. doi: 10.1126/sciadv.adq6858. Epub 2024 Oct 23.
Mammalian cells make the decision to divide at the G-S transition in response to diverse signals impinging on the retinoblastoma protein Rb, a cell cycle inhibitor and tumor suppressor. Passage through the G-S transition is initially driven by Rb inactivation via phosphorylation and by Rb's decreasing concentration in G. While many studies have identified the mechanisms of Rb phosphorylation, the mechanism underlying Rb's decreasing concentration in G was unknown. Here, we found that Rb's concentration decrease in G requires the E3 ubiquitin ligase UBR5. knockout cells have increased Rb concentration in early G, exhibited a lower G-S transition rate, and are more sensitive to inhibition of cyclin-dependent kinase 4/6 (Cdk4/6). This last observation suggests that UBR5 inhibition can strengthen the efficacy of Cdk4/6 inhibitor-based cancer therapies.
哺乳动物细胞在 G1/S 转换时做出分裂的决定,以响应作用于视网膜母细胞瘤蛋白 Rb 的各种信号,Rb 是一种细胞周期抑制剂和肿瘤抑制因子。G1/S 转换最初是由 Rb 通过磷酸化失活以及 Rb 在 G1 期浓度降低驱动的。虽然许多研究已经确定了 Rb 磷酸化的机制,但 Rb 在 G1 期浓度降低的机制尚不清楚。在这里,我们发现 Rb 在 G1 期的浓度降低需要 E3 泛素连接酶 UBR5。UBR5 敲除细胞在 G1 早期的 Rb 浓度增加,G1/S 转换率降低,对细胞周期蛋白依赖性激酶 4/6(Cdk4/6)的抑制更为敏感。最后这一观察结果表明,UBR5 抑制可以增强基于 Cdk4/6 抑制剂的癌症疗法的疗效。